• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban.接受维生素K拮抗剂或利伐沙班治疗的抗磷脂抗体患者的复发性血栓形成。
Haematologica. 2018 Jul;103(7):e315-e317. doi: 10.3324/haematol.2017.185132. Epub 2018 Mar 8.
2
The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.56 例抗磷脂综合征患者使用直接口服抗凝剂。
Thromb Res. 2017 Apr;152:93-97. doi: 10.1016/j.thromres.2016.12.009. Epub 2016 Dec 14.
3
Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban.利伐沙班应用后灾难性抗磷脂综合征。
Lupus. 2020 Jun;29(7):787-790. doi: 10.1177/0961203320914363. Epub 2020 Mar 29.
4
[Not Available].[无可用内容]。
Hamostaseologie. 2019 Aug;39(3):298-300. doi: 10.1055/s-0039-1694789. Epub 2019 Aug 12.
5
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome.利伐沙班与维生素K拮抗剂治疗抗磷脂综合征的比较
Ann Intern Med. 2019 Nov 19;171(10). doi: 10.7326/P19-0013. Epub 2019 Oct 15.
6
Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?直接口服抗凝剂：血栓性抗磷脂综合征的替代治疗方法？
Lupus. 2017 Oct;26(12):1297-1303. doi: 10.1177/0961203317701841. Epub 2017 Mar 29.
7
Recurrent Thrombosis in Patients with Antiphospholipid Syndrome Receiving Newer Oral Anticoagulants: A Case Report and Review of Literature.接受新型口服抗凝剂治疗的抗磷脂综合征患者复发性血栓形成：一例报告及文献综述
Clin Med Res. 2017 Jun;15(1-2):41-44. doi: 10.3121/cmr.2017.1349.
8
[Contemporary approaches to determine the duration of anticoagulant therapy for venous thromboembolism].[确定静脉血栓栓塞症抗凝治疗持续时间的当代方法]
Khirurgiia (Mosk). 2019(5):94-103. doi: 10.17116/hirurgia201905194.
9
Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism.接受利伐沙班和维生素K拮抗剂治疗的女性月经过多与复发性静脉血栓栓塞风险
Vascul Pharmacol. 2016 Dec;87:242-247. doi: 10.1016/j.vph.2016.11.003. Epub 2016 Nov 16.
10
Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants.
Int J Cardiol. 2015;186:141-2. doi: 10.1016/j.ijcard.2015.03.234. Epub 2015 Mar 18.

引用本文的文献

1
Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis.评估直接口服抗凝剂与维生素K拮抗剂相比在抗磷脂综合征患者中的疗效和安全性：更新的系统评价和荟萃分析
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251364269. doi: 10.1177/10760296251364269. Epub 2025 Aug 1.
2
Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications.他汀类药物作为血栓性抗磷脂综合征的辅助抗栓药物：作用机制及临床意义
Cells. 2025 Feb 28;14(5):353. doi: 10.3390/cells14050353.
3
[Vertebral fractures combined with prolonged activated partial prothrombin time: A case report].[椎体骨折合并活化部分凝血活酶时间延长：一例报告]
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Apr 18;56(2):371-374. doi: 10.19723/j.issn.1671-167X.2024.02.028.
4
Embolic Phenomena of Libman-Sacks Endocarditis and Antiphospholipid Syndrome.利布曼-萨克斯心内膜炎和抗磷脂综合征的栓塞现象
Cureus. 2023 Oct 13;15(10):e46957. doi: 10.7759/cureus.46957. eCollection 2023 Oct.
5
Complement biomarkers in the antiphospholipid syndrome - Approaches to quantification and implications for clinical management.抗磷脂综合征中的补体生物标志物——定量方法及对临床管理的影响。
Clin Immunol. 2023 Dec;257:109828. doi: 10.1016/j.clim.2023.109828. Epub 2023 Oct 31.
6
Antiphospholipid antibodies in pulmonary embolism treated with direct oral anticoagulants: Prevalence data from unselected consecutive patients.直接口服抗凝剂治疗的肺栓塞患者中的抗磷脂抗体：来自未经选择的连续患者的患病率数据。
Res Pract Thromb Haemost. 2023 Jan 18;7(1):100050. doi: 10.1016/j.rpth.2023.100050. eCollection 2023 Jan.
7
Lessons Learned From a Case of Behcet's Disease Presenting With Fever and Life-Threatening Venous Thromboembolism.从一例以发热和危及生命的静脉血栓栓塞为表现的白塞病病例中吸取的教训
Cureus. 2022 Dec 15;14(12):e32546. doi: 10.7759/cureus.32546. eCollection 2022 Dec.
8
Anticoagulant Therapy in Patients with Antiphospholipid Syndrome.抗磷脂综合征患者的抗凝治疗
J Clin Med. 2022 Nov 26;11(23):6984. doi: 10.3390/jcm11236984.
9
Cilioretinal artery occlusion in antiphospholipid syndrome and the decision to anticoagulate.抗磷脂综合征中的睫状视网膜动脉阻塞和抗凝治疗决策。
BMJ Case Rep. 2022 Nov 16;15(11):e249509. doi: 10.1136/bcr-2022-249509.
10
Efficacy and Safety of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis.直接口服抗凝剂在抗磷脂综合征患者中的疗效和安全性：一项系统评价和荟萃分析
Cureus. 2022 Sep 22;14(9):e29449. doi: 10.7759/cureus.29449. eCollection 2022 Sep.

本文引用的文献

1
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.利伐沙班联合或不联合阿司匹林治疗稳定的外周动脉或颈动脉疾病患者：一项国际、随机、双盲、安慰剂对照试验。
Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10.
2
Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?直接口服抗凝剂：血栓性抗磷脂综合征的替代治疗方法？
Lupus. 2017 Oct;26(12):1297-1303. doi: 10.1177/0961203317701841. Epub 2017 Mar 29.
3
The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.56 例抗磷脂综合征患者使用直接口服抗凝剂。
Thromb Res. 2017 Apr;152:93-97. doi: 10.1016/j.thromres.2016.12.009. Epub 2016 Dec 14.
4
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.直接口服抗凝药物在抗磷脂综合征中的应用：这些药物是否是华法林的有效且安全的替代药物？文献系统评价。
Curr Rheumatol Rep. 2016 Dec;18(12):74. doi: 10.1007/s11926-016-0623-7.
5
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.利伐沙班与华法林治疗血栓形成性抗磷脂综合征患者（无论是否合并系统性红斑狼疮）（RAPS）：一项随机、对照、开放标签的2/3期非劣效性试验。
Lancet Haematol. 2016 Sep;3(9):e426-36. doi: 10.1016/S2352-3026(16)30079-5.
6
Rivaroxaban - a safe therapeutic option in patients with antiphospholipid syndrome? Our experience in 23 cases.利伐沙班——抗磷脂综合征患者的安全治疗选择？我们对23例患者的经验。
Reumatologia. 2016;54(3):146-9. doi: 10.5114/reum.2016.61217. Epub 2016 Jul 18.
7
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH.非手术患者心房颤动和静脉血栓栓塞性疾病抗凝剂研究中临床相关非大出血的定义：国际血栓与止血学会科学与标准化委员会的沟通
J Thromb Haemost. 2015 Nov;13(11):2119-26. doi: 10.1111/jth.13140.
8
Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndrome.抗磷脂综合征中口服直接凝血酶和因子 Xa 抑制剂的安全性和有效性。
Autoimmun Rev. 2015 Aug;14(8):680-5. doi: 10.1016/j.autrev.2015.03.007. Epub 2015 Apr 9.
9
Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH.使用固相分析法检测抗磷脂抗体：国际血栓与止血学会（ISTH）科学标准化委员会的指南
J Thromb Haemost. 2014 May;12(5):792-5. doi: 10.1111/jth.12537.
10
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies.抗磷脂抗体阳性患者血栓形成的预防和长期管理的循证建议：第 13 届国际抗磷脂抗体大会专题工作组报告。
Lupus. 2011 Feb;20(2):206-18. doi: 10.1177/0961203310395803.

Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban.

作者信息

Martinelli Ida, Abbattista Maria, Bucciarelli Paolo, Tripodi Armando, Artoni Andrea, Gianniello Francesca, Novembrino Cristina, Peyvandi Flora

机构信息

A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy

A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy.

出版信息

Haematologica. 2018 Jul;103(7):e315-e317. doi: 10.3324/haematol.2017.185132. Epub 2018 Mar 8.

DOI:10.3324/haematol.2017.185132
PMID:29519861
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6029544/
Abstract
摘要